Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > The Art of Synthetic Biology Governance: Considering the Concepts of Scientific Uncertainty and Cross-Borderness

Abstract:
Governments around the world are considering how to regulate synthetic biology in an effort to maximize the benefits of the emerging technology while minimizing the risks.

The Art of Synthetic Biology Governance: Considering the Concepts of Scientific Uncertainty and Cross-Borderness

Washington, DC | Posted on March 21st, 2012

But it is crucial for any governance of the technology to address the concepts of "scientific uncertainty" and "cross-borderness," according to a new working paper from the London School of Economics and Political Science's Centre for the Study of Bioscience, Biomedicine, Biotechnology and Society (BIOS).

The authors of the paper, The Transnational Governance of Synthetic Biology: Scientific Uncertainty, Cross-Borderness and the ‘Art' of Governance, argue that the implications of synthetic biology are "not only difficult to predict but are fundamentally unknowable." Further, they stress the concept of cross-borderness -- the need for strong inter-relations between geopolitical regions, academics disciplines and industrial sectors.

To best consider these concepts, the authors recommend a "flexible and evolving ‘art of governance'" for synthetic biology, which would allow for communication between key actors and ensure that stakeholders are able to express their perspectives. The authors base their conclusions on an extensive literature review and work in the United Kingdom, China and Japan.

Join us at the Woodrow Wilson International Center for Scholars on March 27 for a discussion with Dr. Claire Marris, a senior research fellow at King's College London and one of the report's authors, about the findings and their implications for the governance of synthetic biology.

Read more about the BIOS report and to download a copy here:

www.synbioproject.org/news/project/lse_report/

You must register to attend the event.

Visit [www.wilsoncenter.org/event/rsvp?eid=22807&pid=116] to RSVP

What: The Art of Synthetic Biology Governance: Considering the Concepts of Scientific Uncertainty and Cross-Borderness

When: March 27, 2012 from 12:30 p.m. - 2:00 p.m. (Light lunch available at noon.)

Who: Dr. Claire Marris, King's College London

David Rejeski, Director, Science and Technology Innovation Program, will moderate the session

Where: Woodrow Wilson International Center for Scholars

5th Floor Conference Room
Ronald Reagan Building
1300 Pennsylvania Ave NW
Washington, D.C.

For directions, visit: www.wilsoncenter.org/directions

To learn more about the Synthetic Biology Project, visit: www.synbioproject.org/about/

####

For more information, please click here

Copyright © The Woodrow Wilson International Center for Scholars

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Photonic chip guides single photons, even when there are bends in the road February 16th, 2018

Arrowhead Receives Regulatory Clearance to Begin Phase 1/2 Study of ARO-HBV for Treatment of Hepatitis B February 15th, 2018

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-AAT February 15th, 2018

European & Korean Project To Demo World’s First 5G Platform During Winter Games February 15th, 2018

Synthetic Biology

Synthetic protein packages its own genetic material and evolves computationally designed protein assemblies are advancing research in synthetic life and in targeted drug delivery December 15th, 2017

Report highlights opportunities and risks associated with synthetic biology and bioengineering November 22nd, 2017

Living computers: RNA circuits transform cells into nanodevices July 27th, 2017

In-cell molecular sieve from protein crystal February 14th, 2017

Govt.-Legislation/Regulation/Funding/Policy

Arrowhead Receives Regulatory Clearance to Begin Phase 1/2 Study of ARO-HBV for Treatment of Hepatitis B February 15th, 2018

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-AAT February 15th, 2018

Rutgers-Led Innovation Could Spur Faster, Cheaper, Nano-Based Manufacturing: Scalable and cost-effective manufacturing of thin film devices February 14th, 2018

Understanding brain functions using upconversion nanoparticles: Researchers can now send light deep into the brain to study neural activities February 14th, 2018

Announcements

Photonic chip guides single photons, even when there are bends in the road February 16th, 2018

Arrowhead Receives Regulatory Clearance to Begin Phase 1/2 Study of ARO-HBV for Treatment of Hepatitis B February 15th, 2018

Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-AAT February 15th, 2018

European & Korean Project To Demo World’s First 5G Platform During Winter Games February 15th, 2018

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project